Literature DB >> 9663625

Enough sterile syringes to prevent HIV transmission among injection drug users in Montreal?

R S Remis1, J Bruneau, C A Hankins.   

Abstract

The HIV epidemic among injection drugs users in Montreal continues unabated. We wished to know whether sufficient syringes were being distributed to provide for the needs of injection drug users (IDUs) in Montreal. Using data from several sources, including the estimated number of active IDUs in 1994 and the injection frequency according to the drug consumed, we calculated the number of syringes required by IDUs. The number of syringes estimated was compared with the number of syringes distributed by needle exchange programs or sold in private pharmacies. Overall, we estimated that in 1994 about 10,683,000 syringes were required by the 10,000 IDUs in Montreal. Because about 338,000 syringes were distributed, <5% of the need was being met. The parameters in our analysis, particularly the number of IDUs in Montreal, drug use, and the frequency of injection, are subject to uncertainty. Nevertheless, because of the disparity between the small proportion of syringes distributed and the number required, it is unlikely that sufficient syringes are available to ensure access to clean needles and prevent HIV transmission. Measures should be taken to expand syringe distribution to Montreal IDUs.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9663625     DOI: 10.1097/00042560-199802001-00011

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr Hum Retrovirol        ISSN: 1077-9450


  11 in total

1.  Injection drug use and preventive measures: a comparison of Canadian and western European jurisdictions over time.

Authors:  B Fischer; J Rehm; T Blitz-Miller
Journal:  CMAJ       Date:  2000-06-13       Impact factor: 8.262

2.  Correlates of syringe coverage for heroin injection in 35 large metropolitan areas in the US in which heroin is the dominant injected drug.

Authors:  Barbara Tempalski; Hannah L Cooper; Samuel R Friedman; Don C Des Jarlais; Joanne Brady; Karla Gostnell
Journal:  Int J Drug Policy       Date:  2008-03-04

3.  Access to sterile injecting equipment is more important than awareness of HCV status for injection risk behaviors among drug users.

Authors:  Joseph Cox; Carole Morissette; Prithwish De; Claude Tremblay; Robert Allard; Lisa Graves; Randolph Stephenson; Elise Roy
Journal:  Subst Use Misuse       Date:  2009       Impact factor: 2.164

4.  The Chinese government's response to drug use and HIV/AIDS: a review of policies and programs.

Authors:  Jianhua Li; Toan H Ha; Cunmin Zhang; Hongjie Liu
Journal:  Harm Reduct J       Date:  2010-03-05

5.  Trends in production, trafficking, and consumption of methamphetamine and cocaine in Mexico.

Authors:  Kimberly C Brouwer; Patricia Case; Rebeca Ramos; Carlos Magis-Rodríguez; Jesus Bucardo; Thomas L Patterson; Steffanie A Strathdee
Journal:  Subst Use Misuse       Date:  2006       Impact factor: 2.164

6.  Drug-related deaths and the sales of needles through pharmacies.

Authors:  Peter J Davidson; Alexis Martinez; Alexandra Lutnick; Alex H Kral; Ricky N Bluthenthal
Journal:  Drug Alcohol Depend       Date:  2014-12-02       Impact factor: 4.492

7.  My place, your place, or a safer place: the intention among Montréal injecting drug users to use supervised injecting facilities.

Authors:  Traci C Green; Catherine A Hankins; Darlène Palmer; Jean-François Boivin; Robert Platt
Journal:  Can J Public Health       Date:  2004 Mar-Apr

8.  Integrating HIV care and HIV prevention: legal, policy and programmatic recommendations.

Authors:  Robert H Remien; Alan Berkman; Landon Myer; Francisco I Bastos; Ashraf Kagee; Wafaa M El-Sadr
Journal:  AIDS       Date:  2008-08       Impact factor: 4.177

9.  The North American Opiate Medication Initiative (NAOMI): profile of participants in North America's first trial of heroin-assisted treatment.

Authors:  Eugenia Oviedo-Joekes; Bohdan Nosyk; Suzanne Brissette; Jill Chettiar; Pascal Schneeberger; David C Marsh; Michael Krausz; Aslam Anis; Martin T Schechter
Journal:  J Urban Health       Date:  2008-08-29       Impact factor: 3.671

10.  HIV, hepatitis C, and hepatitis B infections and associated risk behavior in injection drug users, Kabul, Afghanistan.

Authors:  Catherine S Todd; Abdullah M S Abed; Steffanie A Strathdee; Paul T Scott; Boulos A Botros; Naqibullah Safi; Kenneth C Earhart
Journal:  Emerg Infect Dis       Date:  2007-09       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.